Office of Research & Development |
|
Project Number: I01BX002301-05
Title: Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival
Principal Investigator: Ann Richmond
FY 2018 Funding Amount: $162,500
Location: Nashville, TN Research Service: Biomedical Laboratory R&D Project Period: January 2018 - December 2021 |